Quick Links

SARS-CoV-2 Tag

The Bioanalytical Chemistry for Medicine and the Environment (BCME) Research Team at the University of Washington is currently recruiting study volunteers across the U.S. for a paid COVID-19 research. This study investigates early immune responses to COVID-19 right after infection, before symptoms develop, and follows...

The ACTIV-2 trial is an adaptive design study that prioritizes the development of promising new therapeutics to expand our treatments of COVID-19. We're testing different medicines to see if they're safe and can help adults recover more quickly. Teams of dedicated researchers want to ensure...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] This study will assess the immune responses to SARS-CoV-2/COVID-19 in three different groups. The body fights infection by producing different types of white blood cells that defend against foreign substances like viruses and bacteria. This process is called...

SITE PARTNERS
uw-footer